Abstract
Cocaine is believed to work by blocking the dopamine transporter (DAT) and thereby increasing the availability of free dopamine within the brain1ā4. Although this concept is central to current cocaine research and to treatment development, a direct relationship between DAT blockade and the subjective effects of cocaine has not been demonstrated in humans. We have used positron emission tomography to determine what level of DAT occupancy is required to produce a subjective 'high' in human volunteers who regularly abuse cocaine. We report here that intravenous cocaine at doses commonly abused by humans (0.3ā0.6 mg kgā1) blocked between 60 and 77% of DAT sites in these subjects. The magnitude of the self-reported high was correlated with the degree of DAT occupancy, and at least 47% of the transporters had to be blocked for subjects to perceive cocaine's effects. Furthermore, the time course for the high paralleled that of cocaine concentration within the striatum, a brain region implicated in the control of motivation and reward. This is the first demonstration in humans that the doses used by cocaine abusers lead to significant blockade of DAT, and that this blockade is associated with the subjective effects of cocaine. Although these findings provide justification to target the DAT for medication development they suggest that for drugs to be effective in blocking cocaine's effects they would have to be given at doses that achieve almost complete DAT occupancy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219ā1223 (1987).
Koob, G. F. & Bloom, F. E. Cellular and molecular mechanism of drug dependence. Science 242, 715ā723 (1988).
Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R. & Spealman, R. D. Effects of cocaine and related drugs in non-human primates. I: [3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251, 131ā141 (1989).
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606ā612 (1996).
Fowler, J. et al. Mapping cocaine-binding sites in human and baboon brain in vivo. Synapse 4, 371ā377 (1989).
Pogun, S., Scheffel, U. & Kuhar, M. J. Cocaine displaces 3H-WIN 35,248 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12,909. Eur. J. Pharmacol. 198, 203ā205 (1991).
Gatley, S. J. et al. Displacement of RTI-55 from the dopamine transporter by cocaine. Eur. J. Pharmacol. 296, 145ā151 (1996).
Logan, J. et al. Effects of blood flow on [11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab. 14, 995ā1010 (1994).
Nestler, E. J. Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439ā2450 (1992).
Volkow, N. D. et al. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 123, 26ā33 (1996).
Fischman, M. W. & Foltin, R. W. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br. J. Addiction 86, 1563ā1570 (1991).
Fischman, M. W. in Testing for Abuse Liability of Drugs in Humans, NIDA Research Monographs Vol. 92 (eds Fischman, M. W. & Mello, N. H.) 211ā230 (Government Printing Office, Washington DC, 1989).
Pettit, H. O. & Justice, J. B. Effect of dose in cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 539, 94ā102 (1991).
Balster, R. L. & Schuster, C. R. Fixed interval schedule of cocaine reinforcement: effect of dose and infusion duration. J. Exp. Anal. Behav. 20, 119ā129 (1973).
Stathis, M. et al. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119, 376ā384 (1995).
Verbey, K. & Gold, M. S. From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psychiatr. Ann. 18, 513ā520 (1988).
Rothman, R. B. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci. 46, 17ā21 (1990).
Pettit, H. O., Ettenberg, A., Bloom, F. E. & Koob, G. F. Destruction of dopamine in the nucleus accumbens selectively attentuates cocaine but not heroin self-administration in rats. Psychopharmacology 84, 167ā173 (1984).
Pontieri, F. E., Tanda, G., Orzi, F. & Di Chiara, G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255ā257 (1996).
Izenwasser, S., Werling, L. L. & Cox, B. M. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520, 303ā309 (1990).
Javaid, J. L., Fischman, M. W., Schuster, C. R., Dekirmenjiian, H. & Davis, J. M. Cocaine plasma concentration: relation to physiological and subjective effects in human. Science 202, 227ā228 (1978).
Gatley, S. J. et al. A model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11 labeled cocaine. Biochem. Pharmacol. 51, 43ā52 (1997).
Volkow, N. D. et al. Carbon-11-cocaine binding compared at sub-pharmacological and pharmacological doses: a PET study. J. Nucl. Med. 36, 1289ā1297 (1995).
Logan, J. et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(l)-cocainePETstudies in human subjects. J. Cereb. Blood Flow Metab. 10, 740ā747 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volkow, N., Wang, GJ., Fischman, M. et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386, 827ā830 (1997). https://doi.org/10.1038/386827a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/386827a0
This article is cited by
-
Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier
Fluids and Barriers of the CNS (2024)
-
Imaging Procedure and Clinical Studies of [18F]FP-CIT PET
Nuclear Medicine and Molecular Imaging (2024)
-
Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release
Translational Psychiatry (2023)
-
A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice
European Journal of Nuclear Medicine and Molecular Imaging (2023)
-
Repeated dosing with cocaine produces strain-dependent effects on responding for conditioned reinforcement in Collaborative Cross mice
Psychopharmacology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.